Last year this Advanced Pharmaceutical small-cap company share traded at a price of ₹140 & now it is trading at ₹4000 which is more than 30x return in 1 year.
Remedium Lifecare Ltd a smallcap company in the business of trading in Advanced Pharmaceutical Intermediates and other pharma products announced a 9:5 bonus issue.
Remedium Lifecare Bonus details
|Company Name||Ex Date||Purpose||Record Date|
|Remedium Lifecare Ltd||28 Jul 2023||Bonus issue 9:5||29 Jul 2023|
Company does trading and sale of API intermediates (KSMs & CRMs) and various other raw materials used in API trading to innovator and generic pharmaceutical players in Domestic and International markets
a) Active Pharmaceutical Ingredients: Lipid Lowering Agent, Antidepressant, Anti-Asthmatic, Anti-Histamine, Proton Pump Inhibitor, Active mucolytic agent, Anti-Hypertension, Decongestant, Anti-emetic, Anti-convulsant
b) CRMs and advanced intermediates: Tartaric Acid Salt, ThiopheneTosylate, Couple Amine Hydrochloride, Pantoprazole Sulphide, Chloro Compound, Cetirizine Base, Levo CBP
In FY22, company generated its entire revenue from Sale of Products
Figures in Rs. Crores
|Mar 2022||Dec 2022||Mar 2023|
|Other Income +||0.00||0.02||0.00|
|Profit before tax||-0.72||1.52||-2.81|
|Net Profit +||-1.16||1.52||-4.78|
|EPS in Rs||-3.22||4.22||-13.28|
On 14th November 2022, company approved Memorandum of Understanding for proposed merger of MVK Lifesciences Private Limited into company for strategic reasons.